MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Show more
Cash Flow Overview
Change in Cash
$584M
Free Cash flow
$10,253M
Unit: Million (M) dollars
Positive Cash Flow Breakdown
Net earnings
Accounts receivable
Maturities of investments
Others
Negative Cash Flow Breakdown
Purchases of investments
Repayments of short-term borrowi...
Cash dividends paid
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net earnings
5,670
6,481
218
2,543
Depreciation and amortization
1,040
1,029
1,117
1,099
Deferred income taxes
-129
540
-733
-932
Share-based compensation
276
348
176
223
Loss on sale of subsidiary and subsidiaries held for sale
-61
-72
-126
-83
Net gains on dispositions and other strategic transactions
-
-
910
-
Other, net
-69
304
-1,609
63
Accounts receivable
-5,025
3,544
829
-1,746
Other assets
-101
-2,919
1,501
962
Medical costs payable
-716
296
-354
1,807
Accounts payable and other liabilities
97
1,055
2,082
63
Unearned revenues
-442
20
107
338
Cash flows from operating activities
11,052
8,912
1,108
5,945
Purchases of investments
3,610
6,515
4,568
4,625
Sales of investments
786
1,878
1,343
2,764
Maturities of investments
2,425
2,285
1,929
2,191
Cash paid for acquisitions and other transactions, net of cash assumed
98
0
73
3,702
Purchases of property, equipment and capitalized software
799
763
948
890
Loans to care providers - cyberattack
-
-
0
0
Repayments of care provider loans - cyberattack
115
82
137
1,543
Originations and purchases of loans
1,530
1,215
4,795
-
Repayments and maturities of loans
725
699
1,980
-
Cash received from dispositions and other strategic transactions, net
10
1,081
561
-
Other, net
-178
-21
-1,823
546
Cash flows used for investing activities
-1,798
-2,447
-2,611
-4,558
Common share repurchases
1,646
0
0
0
Cash dividends paid
2,087
2,005
2,002
2,002
Proceeds from common stock issuances
128
231
24
222
Repayments of long-term debt
1,000
1,500
1,050
2,000
Repayments of short-term borrowings, net
-3,413
1,100
-662
2,872
Proceeds from issuance of long-term debt
0
-
0
0
Customer funds administered
-268
600
2,158
-1,767
Purchases of redeemable noncontrolling interests
-
-
165
-
Other, net
-337
-1,418
666
-90
Cash flows used for financing activities
-8,623
-2,992
-1,031
-2,765
Effect of exchange rate changes on cash and cash equivalents
4
-7
15
-4
Increase in cash and cash equivalents, including cash within businesses held for sale
635
1,539
-
-1,382
Less net increase in cash within businesses held for sale
-
-
-355
-
Less net change in cash within businesses held for sale
-51
199
-
-4
Net increase in cash and cash equivalents
584
3,636
-2,845
-1,386
Cash and cash equivalents, beginning of period
27,210
28,596
-
30,717
Cash and cash equivalents, end of period
28,585
28,001
-
27,210
Page 1
Unit: Million (M) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net earnings
$5,670M
(58.73%↑ Y/Y)
Accounts receivable
-$5,025M
(-80.69%↓ Y/Y)
Depreciation and
amortization
$1,040M
(-4.06%↓ Y/Y)
Share-based compensation
$276M
(40.10%↑ Y/Y)
Other assets
-$101M
(-106.32%↓ Y/Y)
Accounts payable and
other liabilities
$97M
(-23.62%↓ Y/Y)
Other, net
-$69M
(-130.00%↓ Y/Y)
Loss on sale of
subsidiary and...
-$61M
(-48.78%↓ Y/Y)
Cash flows from
operating activities
$11,052M
(53.76%↑ Y/Y)
Effect of exchange rate
changes on cash and cash...
$4M
(-71.43%↓ Y/Y)
Canceled cashflow
$1,287M
Increase in cash and cash
equivalents, including cash...
$635M
(129.04%↑ Y/Y)
Canceled cashflow
$10,421M
Medical costs payable
-$716M
(-151.96%↓ Y/Y)
Unearned revenues
-$442M
(-62.50%↓ Y/Y)
Deferred income taxes
-$129M
(14.57%↑ Y/Y)
Proceeds from common
stock issuances
$128M
(-42.08%↓ Y/Y)
Maturities of investments
$2,425M
(12.32%↑ Y/Y)
Sales of investments
$786M
(-60.62%↓ Y/Y)
Repayments and maturities
of loans
$725M
Other, net
-$178M
(-117.18%↓ Y/Y)
Repayments of care provider
loans - cyberattack
$115M
(-71.39%↓ Y/Y)
Cash received from
dispositions and other...
$10M
Net increase in cash
and cash...
$584M
(127.53%↑ Y/Y)
Canceled cashflow
$51M
Cash flows used for
financing activities
-$8,623M
(-8.51%↓ Y/Y)
Cash flows used for
investing activities
-$1,798M
(-24.69%↓ Y/Y)
Canceled cashflow
$128M
Canceled cashflow
$4,239M
Less net change in
cash within...
-$51M
(-177.27%↓ Y/Y)
Repayments of short-term
borrowings, net
-$3,413M
(35.77%↑ Y/Y)
Cash dividends paid
$2,087M
(4.35%↑ Y/Y)
Common share
repurchases
$1,646M
(-35.32%↓ Y/Y)
Repayments of long-term
debt
$1,000M
Other, net
-$337M
(-4112.50%↓ Y/Y)
Customer funds
administered
-$268M
(78.90%↑ Y/Y)
Purchases of investments
$3,610M
(-10.75%↓ Y/Y)
Originations and purchases of
loans
$1,530M
Purchases of property,
equipment and capitalized...
$799M
(-9.82%↓ Y/Y)
Cash paid for
acquisitions and other...
$98M
(206.25%↑ Y/Y)
Buy us a coffee
UNITEDHEALTH GROUP INC (UNH)
UNITEDHEALTH GROUP INC (UNH)